The cerebral palsy market share is expected to increase by USD 961.91 million from 2020 to 2025, and the market’s growth momentum will accelerate at a CAGR of 5.45%.
This cerebral palsy market research report provides valuable insights on the post-COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers cerebral palsy market segmentation by product (anticonvulsant drugs, antispastic drugs, anticholinergic drugs, NSAIDs, Antidepressants, and others) and geography (North America, Asia, Europe, and ROW). The cerebral palsy market report also offers information on several market vendors, including AbbVie Inc., Acorda Therapeutics Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, GW Pharmaceuticals Plc, Johnson and Johnson Inc., Medtronic Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. among others.
What will the Cerebral Palsy Market Size be During the Forecast Period?
Download the Free Report Sample to Unlock the Cerebral Palsy Market Size for the Forecast Period and Other Important Statistics
Cerebral Palsy Market: Key Drivers, Trends, and Challenges
The rising incidence of cerebral palsy is notably driving the cerebral palsy market growth, although factors such as complex and multifactorial etiology may impede the market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the cerebral palsy industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Cerebral Palsy Market Driver
The rising incidence of cerebral palsy is one of the key drivers supporting the cerebral palsy market share growth. Cerebral palsy is one of the most common types of motor disorders in early childhood. The incidence rate of cerebral palsy is continuously increasing worldwide. Children with a low birth weight are more likely to develop cerebral palsy. The incidence rate is three times more in resource-poor countries compared with developed nations. Meanwhile, prenatal causes are also responsible for about 70% of cerebral palsy cases. The most common prenatal cause is asphyxia neonatorum (when the baby does not get enough oxygen during birth). In most developing countries, a vast majority of the population is ignorant about the importance of prenatal care. The lack of proper prenatal care may increase the chances of children developing cerebral palsy. Thus, the rising incidence of cerebral palsy may drive market growth during the forecast period.
Key Cerebral Palsy Market Trend
The availability of advanced therapeutic modalities for cerebral palsy is another factor driving the cerebral palsy market growth. Conventional treatment options for cerebral palsy include physical therapy, occupational therapy, speech and language therapy, recreational therapy, surgery, and medications. Some technological advances have already been introduced in the market while some are in the late stage of development or in the trial stage for the treatment of cerebral palsy. They include FES, virtual reality, stem cell therapy, and robotics. For example, FES involves the stimulation of muscles using electrical impulses to produce contractions and generate movements. It has been in use for many years for the improvement of movements in patients. Thus, multiple treatment options and disease management options are available for cerebral palsy and to improve the quality of life of patients.
Key Cerebral Palsy Market Challenge
Complex and multifactorial etiology is hampering the cerebral palsy market growth. Defining one particular therapy to target the challenges of cerebral palsy is difficult as the disease has a complex etiology. Various factors contribute to cerebral palsy, including maternal- and infant-related characteristics. The disease is known to be caused by an interplay of certain events during the pre-conceptional, antepartum, intrapartum, and post-neonatal periods. Women with neurological disorders are at an increased risk of giving birth to children with cerebral palsy. Also, the presence of intrapartum fever, which occurs during labor, is a major risk factor for cerebral palsy. Multifetal gestation, placental pathology, genetic factors, birth defects, and thrombophilia are the other general etiological factors that are responsible for cerebral palsy. Thus, the prediction of the exact cause of the disease is a challenge.
This cerebral palsy market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2021-2025.
Parent Market Analysis
Technavio categorizes the cerebral palsy market as a part of the global pharmaceuticals market. Our research report has extensively covered external factors influencing the parent market growth potential in the coming years, which will determine the levels of growth of the cerebral palsy market during the forecast period.
Who are the Major Cerebral Palsy Market Vendors?
The report analyzes the market’s competitive landscape and offers information on several market vendors, including:
- AbbVie Inc.
- Acorda Therapeutics Inc.
- Eli Lilly and Co.
- F. Hoffmann-La Roche Ltd.
- GlaxoSmithKline Plc
- GW Pharmaceuticals Plc
- Johnson and Johnson Inc.
- Medtronic Plc
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
This statistical study of the cerebral palsy market encompasses successful business strategies deployed by the key vendors. The cerebral palsy market is concentrated and the vendors are deploying growth strategies such as operational cost, innovation, competitive pricing, and improvement of product quality to compete in the market.
Product Insights and News
- AbbVie Inc. - The company offers cerebral palsy products under the brand name of Allergan.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The cerebral palsy market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
Cerebral Palsy Market Value Chain Analysis
Our report provides extensive information on the value chain analysis for the cerebral palsy market, which vendors can leverage to gain a competitive advantage during the forecast period. The end-to-end understanding of the value chains is essential in profit margin optimization and evaluation of business strategies. The data available in our value chain analysis segment can help vendors drive costs and enhance customer services during the forecast period.
The value chain of the pharmaceuticals market includes the following core components:
- Integration and product development
- Manufacturing
- Outbound logistics
- Marketing and sales
- Support services
- Innovation
The report has further elucidated on other innovative approaches being followed by service providers to ensure a sustainable market presence.
Which are the Key Regions for Cerebral Palsy Market?
For more insights on the market share of various regions Request for a FREE sample now!
39% of the market’s growth will originate from North America during the forecast period. The US and Canada are the key markets for the cerebral palsy market in North America. Market growth in this region will be slower than the growth of the market in Asia.
Patients in the US are highly dependent on drug therapy for the treatment of cerebral palsy symptoms, which will facilitate the cerebral palsy market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
COVID Impact and Recovery Analysis
The COVID-19 outbreak led to a slight decline in the growth of the cerebral palsy market in North America in Q1 2020, owing to the temporary pause on the research of new drugs for cerebral palsy and reduced clinic visits because of the stay-at-home policy. This led to a decline in the sales of cerebral palsy therapeutics. However, the adoption of telehealth and the lifting of stay-at-home policies regained the market revenue in the region. In addition, fastened research programs for cerebral palsy are expected to drive the growth of the regional market during the forecast period.
What are the Revenue-generating Product Segments in the Cerebral Palsy Market?
To gain further insights on the market contribution of various segments Request for a FREE sample
The cerebral palsy market share growth by the anticonvulsant drugs segment will be significant during the forecast period. The use of anticonvulsants is crucial for the management of cerebral palsy. The sales of leading anticonvulsants, including NEURONTIN, Lamictal, Trileptal, TOPAMAX, and ZONEGRAN, contribute to the market size. The market size for this segment has been derived based on annual sales data as well as the incidence rate of convulsions among patients with cerebral palsy.
This report provides an accurate prediction of the contribution of all the segments to the growth of the cerebral palsy market size and actionable market insights on post COVID-19 impact on each segment.
You may be interested in:
Cerebral Palsy Drugs market - The market share is expected to grow at a CAGR of more than 5% during the 2019-2023 forecast period.
|
Cerebral Palsy Market Scope |
|
|
Report Coverage |
Details |
|
Page number |
120 |
|
Base year |
2020 |
|
Forecast period |
2021-2025 |
|
Growth momentum & CAGR |
Accelerate at a CAGR of 5.45% |
|
Market growth 2021-2025 |
$ 961.91 million |
|
Market structure |
Concentrated |
|
YoY growth (%) |
4.89 |
|
Regional analysis |
North America, Asia, Europe, and ROW |
|
Performing market contribution |
North America at 39% |
|
Key consumer countries |
US, Canada, Australia, China, and UK |
|
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
|
Key companies profiled |
AbbVie Inc., Acorda Therapeutics Inc., Eli Lilly and Co., F. Hoffmann-La Roche Ltd., GlaxoSmithKline Plc, GW Pharmaceuticals Plc, Johnson and Johnson Inc., Medtronic Plc, Pfizer Inc., and Teva Pharmaceutical Industries Ltd. |
|
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
|
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
What are the Key Data Covered in this Cerebral Palsy Market Report?
- CAGR of the market during the forecast period 2021-2025
- Detailed information on factors that will drive cerebral palsy market growth during the next five years
- Precise estimation of the cerebral palsy market size and its contribution to the parent market
- Accurate predictions on upcoming trends and changes in consumer behavior
- The growth of the cerebral palsy industry across North America, Asia, Europe, and ROW
- A thorough analysis of the market’s competitive landscape and detailed information on vendors
- Comprehensive details of factors that will challenge the growth of cerebral palsy market vendors
We can help! Our analysts can customize this report to meet your requirements. Get in touch